Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

EP-NIR Analyzers

By Drug Discovery Trends Editor | October 5, 2007

SpectrometersAspectrics manufactures a complete line of Infrared and Near Infrared spectrometers for both at-line and on-line process related applications. The company’s ncoded Photometric Infrared (EP-IR) and Near Infrared (EP-NIR) analyzers offer an alternative to traditional NIR systems, with a spectral range extending further than the common 2100nm and achieving a range of 1375-2750nm.

Aspectrics’ EP-IR technology allows users to monitor their processes in real-time. The company’s patented Encoder Disk technology provides a fast sampling capability of 100 scans/second resulting in multi component analysis. Achieving this fast scan rate and with an extended warranty of ten years on the motor, Aspectrics offers 30 billion scans over the life of the instrument or 10 years of life.

Aspectrics has recently extended its one year warranty on its EP-NIR and EP-IR spectrometers to three years for parts and labor as well as adding a new ten year parts and labor warranty on the encoder disk motor. In addition, the warranties now include all parts and labor for repair at the company’s Pleasanton, Calif. facility.
www.aspectrics.com

Published in Drug Discovery & Development magazine: Vol. 10, No. 8, August, 2007, p.34.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50